Video modal
popup modal
The MHICC is now Seriant !
The Montreal Health Innovations Coordinating Center (MHICC) is now Seriant.
Our new name reflects a bold step forward— expanding beyond cardiology and embracing innovations in clinical trials with a global reach.
While our identity has evolved, our commitment to operational excellence, client satisfaction, and quality remains the same.
MHICC Becomes Seriant: A New Chapter in Clinical Trial Excellence
April 1, 2025
Montréal, QC — April 1, 2025 — The Montreal Health Innovations Coordinating Center (MHICC) today unveiled its new name and identity: Seriant. The rebrand reflects the organization’s evolution into a full-service contract research organization (CRO) focused on clinical trial excellence from Phase I to IV.
Founded at the Montreal Heart Institute in 2001, the organization began as a cardiology-focused CRO. Over the past two decades, it has grown into a trusted partner for academic, pharmaceutical, biotech, and medical device companies around the world. The new name signals this growth—highlighting broader capabilities, a global reach, and a continued commitment to operational excellence, advanced solutions, and client satisfaction.
The organization remains deeply committed to the principles that shaped its legacy within the Montreal Heart Institute while embracing new fields of innovation such as precision medicine, decentralized trials, and prevention-focused research.
“This is an important milestone in our journey—our new identity marks a natural evolution from a cardiology-focused academic research group to a full-service CRO embracing broader therapeutic areas,” said Sophie Tanguay, Executive Director at Seriant.
To learn more, visit Seriant.org
Seriant.
Transforming Lives, One Study at a Time.
About Seriant
Formerly known as the Montreal Health Innovations Coordinating Center (MHICC), Seriant is a full-service Contract Research Organization (CRO) with over 25 years of experience in clinical trials. With deep roots in academic research and a focus on precision, innovation, and collaboration, Seriant offers tailored clinical trial services across a number of therapeutic areas. Headquartered in Montréal, Seriant operates internationally by partnering with pharmaceutical, biotechnology, and medical device companies and academic sponsors to bring therapies to life—through every phase of research.
